市場調查報告書

全球細胞增生市場:成長,趨勢,預測(2020年∼2025年)

Cell Expansion Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 925385
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
全球細胞增生市場:成長,趨勢,預測(2020年∼2025年) Cell Expansion Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

慢性疾病的發生率增加,及細胞型治療方法的研究開發興趣提升等,是帶動細胞增生市場的主要原因。

本報告提供全球細胞增生市場調查,提供市場概要,各產品·用途·電池單元類型·終端用戶·各地區的市場規模的變化與預測,市場趨勢,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 慢性疾病的發生率的增加
    • 政府的投資增加
    • 對研究開發的興趣增加
  • 阻礙市場要素
    • 細胞生物學上研究倫理的疑慮
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭加劇

第5章 市場區隔

  • 各產品
    • 消耗品
    • 試劑,培養基,及血清
    • 設備
  • 各細胞類型
    • 人細胞
    • 動物細胞
  • 各用途
    • 再生醫療·幹細胞研究
    • 癌症·細胞為基礎的研究
    • 其他
  • 各終端用戶
    • 生物醫藥品·生物科技企業
    • 研究機關
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Terumo BCT
    • Merck KGaA
    • Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
    • Miltenyi Biotec
    • Lonza Group LTD.
    • Stemcell Technologies, Inc.
    • GE Healthcare
    • Takara Bio Inc.

第7章 市場機會及未來趨勢

目錄
Product Code: 67973

The cell expansion market will show rapid growth due to the increasing incidence of chronic diseases, government investments for cell-based research and increasing focus on R&D for cell-based therapies.

The rising prevalence of chronic diseases coupled with increasing research activities for cell-based research is found to be the major factor driving the cell expansion market. Cardiovascular disease (CVD) is the leading cause of mortality worldwide. According to the WHO, an estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths.

There is an increase in the prevalence of cancer patients that results in a large patient pool, which creates an opportunity for the manufacturers to tap and capitalize on the market. Hence there is an increase in the cases of chronic diseases that are expected to drive the overall market. Furthermore, technological advances in cell expansion devices and growth in government investments regarding healthcare issues are the factors propelling the market.

Key Market Trends

Consumables is Expected to be the Largest Growing Segment in the Cell Expansion Market

The consumables segment has been accounted for the largest share of the market and this is mainly due to the high demand during the production of regenerative medicine and rising research activities on stem cells in the biopharmaceutical companies. There is also a constant requirement for new reagents among end-users that helps in market growth. Furthermore, the rising awareness regarding advanced treatment therapies such as personalized medicine is also another driving factor for this segment.

North America is Found Leading the Cell Expansion Market

The increasing incidences of chronic and cell-based diseases and rising geriatric population are the key factors driving the overall market in this region. The rising investment made by the companies as well as the government for cell expansion research is also a factor driving the market in this region.

The Asia Pacific is poised to grow owing to rapidly expanding biotechnology and biopharmaceutical industries, increasing government investments for cancer and stem cell research and rising focus of prominent players on the emerging markets.

Competitive Landscape

There has been a presence of a considerable number of companies that are mainly focusing on agreements and expansions to strengthen its business operations. There are various established business players that are adopting numerous organic and inorganic growth strategies to increase their market share. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Chronic Diseases
    • 4.2.2 Government Investments for Cell-Based Research
    • 4.2.3 Increasing Focus on R&D for Cell-Based Therapies
  • 4.3 Market Restraints
    • 4.3.1 Ethical Concerns Regarding Research in Cell Biology
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Consumables
    • 5.1.2 Reagents, Media, & Serum
    • 5.1.3 Disposables
    • 5.1.4 Instruments
      • 5.1.4.1 Cell Expansion Supporting Equipment
      • 5.1.4.2 Bioreactors
      • 5.1.4.3 Automated Cell Expansion Systems
  • 5.2 By Cell Type
    • 5.2.1 Human Cells
    • 5.2.2 Animal Cells
  • 5.3 By Application
    • 5.3.1 Regenerative Medicine and Stem Cell Research
    • 5.3.2 Cancer and Cell-Based Research
    • 5.3.3 Other Applications
  • 5.4 By End User
    • 5.4.1 Biotechnology & Biopharmaceutical Companies
    • 5.4.2 Research Institutes
    • 5.4.3 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific, Inc.
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Terumo BCT
    • 6.1.4 Merck KGaA
    • 6.1.5 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
    • 6.1.6 Miltenyi Biotec
    • 6.1.7 Lonza Group LTD.
    • 6.1.8 Stemcell Technologies, Inc.
    • 6.1.9 GE Healthcare
    • 6.1.10 Takara Bio Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS